Relationship Between Trough Levels of Anti-Infliximab and Serum Biomarkers in Patients With Rheumatoid Arthritis

Relationship Between Trough Levels of Anti-Infliximab and Serum Biomarkers in Patients With Rheumatoid Arthritis

Rheumatoid arthritis is a chronic condition, characterized by the expression of antibody against self-antigens. Inflammatory cell of synovial tissues secreted numerous cytokines, include tumor necrosis factor alpha. Infliximab was designed to treat several autoimmune diseases. However, a considerab...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sura Mohammed Lateef, Ahmed Abdul-Hassan Abbas, Mohammed Hadi Alosami
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2025-03-01
Series:	Acta Medica Iranica
Subjects:	Anti cyclic citrullinated protein C reactive protein Infliximab Rheumatoid arthritis Rheumatoid factor
Online Access:	https://acta.tums.ac.ir/index.php/acta/article/view/11278
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

INFLIXIMAB (REMICADE): POSSIBILITIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: Nataliya Vladimirovna Chichasova, et al.
Published: (2011-03-01)

Infliximab in the therapy of rheumatoid arthritis
by: G. V. Lukina, et al.
Published: (2016-05-01)

Cerebrovascular reactivity depending on rheumatoid factor and anticitrullinated protein antibody positivity in hypertensive patients with rheumatoid arthritis
by: N. V. Rebrova, et al.
Published: (2022-07-01)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
by: Hui-Chun Yu, et al.
Published: (2019-01-01)

ACCP-negative rheumatoid arthritis – clinical and immunological features
by: D. A. Dibrov
Published: (2022-07-01)

Dual antibody status predicts sustained remission in patients with rheumatoid arthritis
by: Praveen Pratap Jadhav, et al.
Published: (2019-01-01)

INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS?
by: R M Balabanova, et al.
Published: (2010-03-01)

EFFICACY OF INFLIXIMAB IN RHEUMATOID ARTHRITIS: A RELATIONSHIP TO THE TOTAL DOSE OF THE DRUG
by: E. S. Aronova, et al.
Published: (2015-10-01)

Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease
by: E. L. Nasonov, et al.
Published: (2023-06-01)

Comparative Analysis of Rheumatoid Factor Levels by Immune Turbidimetry and Latex Agglutination Assays among Anti-Cyclic Citrullinated Peptide-Positive Rheumatoid Arthritis Patients
by: Bineeta Kashyap, et al.
Published: (2020-10-01)

Serum calprotectin levels: A measure of disease activity in rheumatoid arthritis
by: Pranshu Dhingra, et al.
Published: (2025-01-01)

INFLIXIMAB-INDUCED LUPUS-LIKE SYNDROME IN A FEMALE PATIENT WITH RHEUMATOID ARTHRITIS (A CASE REPORT): AN ACCIDENT OR REGULARITY?
by: Yu. V. Muravyev, et al.
Published: (2017-09-01)

EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2018-07-01)

Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis
by: D. A. Dibrov, et al.
Published: (2023-04-01)

AUTOANTIBODIES TO CIRTULLINATED ANTIGENS FOR DIAGNOSIS AND PREDICTION OF CLINICAL COURSE IN EARLY RHEUMATOID ARTHRITIS
by: I. B. Belyaeva, et al.
Published: (2014-07-01)

TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: E N Aleksandrova, et al.
Published: (2011-06-01)

Rheumatoid factor and antibodies against cyclic citrullinated peptide in patients without rheumatoid arthritis
by: N. V. Bunchuk
Published: (2023-01-01)

Peculiarities of immunological manifestations in patients with rheumatoid arthritis in the presence of chronic infection with <i>Helicobacter pylori</i> variant encoding cytotoxin-associated gene A
by: A. V. Aleksandrov, et al.
Published: (2023-06-01)

EFFECT OF INFLIXIMAB ON PARAMETERS OF REMODELING OF ARTERIAL BLOODSTREAM, RANKL AND OSTEOPROTEGERIN LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Larisa Aleksandrovna Knyazeva, et al.
Published: (2014-02-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2011-06-01)

Relation of cytokine profile and antibody values to post-translational protein modifications in patients with rheumatoid arthritis (preliminary data)
by: D. А. Dibrov, et al.
Published: (2024-04-01)

Anti-cyclic citrullinated peptide antibodies – a role in rheumatoid arthritis and the possibility of seroconversion: A focus on abatacept
by: N. V. Chichasova
Published: (2017-03-01)

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Elena Nikolayevna Aleksandrova, et al.
Published: (2012-02-01)

Bone destruction in rheumatoid arthritis: role of autoantibodies
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2013-06-01)

Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry
by: Andreina Manfredi, et al.
Published: (2019-01-01)

Seropositive juvenile rheumatoid arthritis: analysis of the spectrum of clinical manifestations and therapy according to a retrospective study
by: М. I. Kaleda, et al.
Published: (2021-02-01)

THE 2016 EULAR GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EARLY ARTHRITIS
by: E. L. Nasonov
Published: (2017-04-01)

Infliximab in Russian clinical practice
by: G V Lukina, et al.
Published: (2012-09-01)

DYNAMICS OF CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS AS INFLUENCED BY INFLIXIMAB (REMIKEID) ADMINISTRATION
by: E. S. Zhugrova, et al.
Published: (2014-07-01)

Relationship of immunogenetic and immunologic markers and their influence on disease activity and radiological progression in patients with early rheumatoid arthritis
by: N V Demidova
Published: (2009-06-01)

INVESTIGATION OF CANDIDATE GENE POLYMORPHISMS IN AN IMMUNE RESPONSE AS MARKERS FOR THE RISK OF DEVELOPING RHEUMATOID ARTHRITIS AND PRODUCING AUTOANTIBODIES
by: I. A. Guseva, et al.
Published: (2016-03-01)

SYNOVIAL MEMBRANE CHANGES IN PATIENTS WITH RHEUMATOID ARTHRITIS REVEALED DURING ARTHROSCOPY
by: E. B. Komarova
Published: (2017-07-01)

Current state and future directions of basic research in rheumatoid arthritis
by: Byeongzu Ghang, et al.
Published: (2025-07-01)

Infliximab tolerance in patients with rheumatoid arthritis in real clinical practice
by: E. S. Aronova, et al.
Published: (2020-02-01)

Bone resorption during therapy with denosumab in patients with rheumatoid arthritis, positive for the main immunological markers
by: P. S. Kovalenko, et al.
Published: (2022-11-01)

C-Reactive Protein to Albumin Ratio and Albumin to Fibrinogen Ratio in Rheumatoid Arthritis Patients
by: Elsabagh Abdou Amira, et al.
Published: (2022-05-01)

Evaluation of myocardial damage in different types of rheumatoid arthritisduring disease-modifying antirheumatic drug or biological therapy (with infliximab)
by: V I Mazurov, et al.
Published: (2010-12-01)

Evaluation of Some Biochemical Factors Associated with Rheumatoid Arthritis
by: Tabarak Siraj Ibrahim, et al.
Published: (2025-07-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

CHANGES IN THE LEVELS OF ANGIOTENSIN II, ALDOSTERONE, AND FIBROBLAST GROWTH FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS IN RELATION TO CLINICAL FEATURES
by: E. B. Komarova, et al.
Published: (2016-07-01)